By Brady Jones, Medill Reports

Slowed reaction time. Reduced ability to make decisions. Impaired coordination. Memory loss. Difficulty in problem-solving. These are some of the symptoms listed by the Centers for Disease Control and Prevention (CDC) describing people who drive under the influence of marijuana. And right now, it is very difficult for law enforcement officials to determine when these drivers are sharing the road with you—and may be responsible for causing an accident.

Continue reading “Stoned Drivers Targeted By New Breathalyzer Technology”

By Jared Sagoff

Every invention and every new piece of technology begins as a bright idea. But to go from mere inspiration to an actual device or real-world solution requires more than just a stroke of insight. Budding entrepreneurs need access to tools, capital, mentors, and expertise as they attempt to bring a product to the marketplace. Continue reading “Argonne’s Demo Day Provides Opportunity For Entrepreneurs To Showcase New Innovations”

By Jared Sagoff

Originally published at: https://www.anl.gov/article/innovationxlab-summit-brings-industry-national-laboratories-together-around-artificial-intelligence

Artificial intelligence (AI) is changing the world around us, from making our cities smarter to paving the way for faster drug discovery. As part of the burgeoning effort to connect different key players in AI, the U.S. Department of Energy’s (DOE) Argonne National Laboratory recently hosted the InnovationXLab℠ Summit on AI to raise the profile of the labs’ work in AIand forge new partnerships between industry and the national laboratories.

Continue reading “InnovationXLab Summit brings industry, national laboratories together around artificial intelligence”

Comment by Robert Kriss, C2ST, Editor

Dr. Ronald Ackerman, director of Northwestern’s Institute for Public Health and Medicine (IPHAM) and the Center for Community Health, is into making house calls, but not the traditional home visits you might have in mind. Dr. Ackerman subscribes to the old adage that an ounce of prevention is worth a pound of cure. He and his colleagues at IPHAM have devised community-based research programs to identify people at risk for diabetes and have developed programs to encourage those people to change their lifestyles to prevent the disease. IPHAM has been a powerhouse for public health and scholarship. Between 2012 and 2017, its members have published more than 15,000 articles, which have been cited more than 227,000 times, and in 2017, its centers received nearly 600 research awards totaling $130 million. Read more about Dr. Ackerman and IPHAM here.

Ending an Epidemic

By Roger Anderson

Originally published at: https://www.research.northwestern.edu/ending-an-epidemic/